Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)
Clinical trial NCT02411539 · COMPLETED
Trial details
- NCT number
- NCT02411539
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-25
- Primary completion
- 2016-04-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.